ProCE Banner Activity

CE

Promise in the Changing Landscape of Schizophrenia Treatment

Video

On-demand webcast of expert faculty presentation and case discussion on new and emerging therapies for treating schizophrenia, as presented at CCO’s Psychiatry Update 2024 for advanced practice providers.

Nurses: 1.50 Nursing contact hours, including 1.50 hours of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.50 AAPA Category 1 CME credits

Released: December 17, 2024

Expiration: December 16, 2025

Share

Faculty

Joseph P. McEvoy

Joseph P. McEvoy, MD

Professor of Psychiatry and Health Behavior
Clark Case Endowed Chair in Psychotic Disorders
Medical College of Georgia
Augusta University
Augusta, Georgia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Target Audience

This activity is intended for healthcare professionals caring for patients with schizophrenia including nurse practitioners, physician associates, and registered nurses.

Program Learning Goal

The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with schizophrenia.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Assess evidence for efficacy and safety profiles of newer agents used in the treatment of schizophrenia

  • Differentiate characteristics of emerging treatments for schizophrenia including novel mechanisms of action, kinetics, efficacy, and AE profiles

  • Recognize the role of newer and emerging agents in addressing unmet needs in the current treatment of schizophrenia

  • Design a patient care plan that integrates novel agents into the current treatment of schizophrenia

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Joseph P. McEvoy, MD

Professor of Psychiatry and Health Behavior
Clark Case Endowed Chair in Psychotic Disorders
Medical College of Georgia
Augusta University
Augusta, Georgia

Joseph P. McEvoy, MD, has no relevant financial relationships to disclose.

Jonathan M. Meyer, MD, DLFAPA: consultant/advisor/speaker: 4MTx, Alkermes, Axsome, Bristol Myers Squibb, Cerevel, ITCI, Neurocrine, Relmada, Sumitomo, Teva.

The planners and content reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Michael Asbach, DMSc, PA-C, and Prakash Masand, MD, as noted below:​

Michael Asbach, DMSc, PA-C: consultant/advisor/speaker: AbbVie, Avanir, Intra-Cellular, Janssen, Neurocrine, Otsuka, Sage/Biogen.​

Prakash Masand, MD: consultant/advisor/speaker: AbbVie, Intracellular, Karuna/BMS, Neumora, Neurocrine, Vanda.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 17, 2024, through December 16, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours, including 1.5 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until December 16, 2025. PAs should only claim credit commensurate with the extent of their participation.